Figure 3.
Sensitivity analyses exploring different SARS-CoV-2 booster and vaccine eligibility criteria, booster and vaccine effectiveness and booster acceptances, France, July 2021–September 2022
SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.
Panel A: Impact of changing the delay between receiving a second dose and being eligible for a booster. Panel B: Impact of an increased acceptance of booster doses and/or a faster roll-out of boosters. Panel C: Impact of more pessimistic assumptions about the waning of protection conferred by vaccination. Panel D: Impact of a higher effectiveness of booster doses. Panel E: Impact of the vaccination of children. In panel B, the trajectories are presented under the assumption that booster doses are distributed in those 18 years and older.
